News | EP Mapping and Imaging Systems | October 29, 2018

First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast

Sheath can be visualized on Carto 3 system during catheter ablation to reduce dependence on fluoroscopy

First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast

October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto Vizigo bi-directional guiding sheath. The sheath can be visualized on the Carto 3 System during a catheter ablation procedure, helping electrophysiologists reduce dependency on fluoroscopy.

A sheath is an introducer routinely used by physicians to facilitate catheter access, stability and tissue contact when targeting sites for catheter ablation to treat arrhythmias. Electrophysiologists rely on fluoroscopy to identify the location of the sheath, therefore requiring use of lead to protect themselves from radiation during the procedure.

According to Ivan Ho, M.D., electrophysiologist practicing at Good Samaritan Hospital and the first to use the technology on the West Coast, the long deflectable sheath has become a major step forward in achieving catheter stability and appropriate radiofrequency energy delivery in complex left-sided arrhythmia ablations. "One of the limitations has been the need of periodic fluoroscopic imaging of the sheath's relative position with the catheter to optimize contact with endocardial surface and ensure safety due to the relatively stiff shaft of these sheaths," said Ho.  The Vizigo allows the direction of the sheath and its relationship with the catheter to be visualized accurately on a 3-D mapping system, minimizing the use of fluoroscopy and overall procedure time.

This new technology is incorporated easily into the physicians' workflow, designed to enhance efficiency during mapping and positioning of the ablation catheter. The smooth tip-to-dilator transition promotes ease of entry into the left atrium during transseptal access, while deflections of 180 degrees in both directions mean increased steerability, which may improve access to hard-to-reach sites.

For more information: www.biosensewebster.com


Related Content

News | EP Mapping and Imaging Systems

May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home May 15, 2023
Home
News | EP Mapping and Imaging Systems
April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...
Home April 29, 2022
Home
News | EP Mapping and Imaging Systems

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...

Home March 03, 2022
Home
Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) ...

Home October 14, 2021
Home
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
Home
News | EP Mapping and Imaging Systems

September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardiac ...

Home September 14, 2020
Home
News | EP Mapping and Imaging Systems

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in ...

Home August 17, 2020
Home
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
Home
News | EP Mapping and Imaging Systems

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced ...

Home October 09, 2019
Home
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
Home
Subscribe Now